GOVX - GeoVax Labs, Inc.
1.71
0.120 7.018%
Share volume: 97,918
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.72%
PREVIOUS CLOSE
CHG
CHG%
$1.59
0.12
0.08%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 05-14-2024 | 08-06-2024 | 11-12-2024 | 03-27-2025 | 05-01-2025 | 07-28-2025 | 11-13-2025 | |
| Assets | ||||||||
| Total Assets | 3.358 M | 4.095 M | 11.112 M | 8.156 M | 10.833 M | 5.350 M | 6.731 M | |
| Current Assets | 2.862 M | 3.844 M | 10.869 M | 7.935 M | 10.612 M | 5.136 M | 6.517 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 768.859 K | 1.562 M | 8.593 M | 5.507 M | 7.439 M | 3.094 M | 5.009 M | |
| Total Non-current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 190.113 K | 170.537 K | 171.615 K | 149.974 K | 149.947 K | 143.862 K | 127.060 K | |
| Other Assets | 305.691 K | 81.010 K | 71.010 K | 71.010 K | 71.010 K | 71.010 K | 86.947 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||||
| Total Liabilities and shareholders’ equity | 3.358 M | 4.095 M | 11.112 M | 8.156 M | 10.833 M | 5.350 M | 6.731 M | |
| Total liabilities | 3.304 M | 6.404 M | 2.608 M | 3.107 M | 2.935 M | 2.529 M | 1.824 M | |
| Total current liabilities | 3.304 M | 6.404 M | 2.608 M | 3.107 M | 2.935 M | 2.529 M | 1.824 M | |
| Accounts Payable | 1.884 M | 3.984 M | 2.148 M | 1.850 M | 2.403 M | 1.830 M | 976.411 K | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 54.275 K | -2.309 M | 8.504 M | 5.049 M | 7.898 M | 2.821 M | 4.907 M | |
| Common stock | 110.268 M | 112.969 M | 129.597 M | 134.405 M | 142.612 M | 142.905 M | 151.310 M | |
| Retained earnings | -110.214 M | -115.278 M | -121.093 M | -129.356 M | -134.714 M | -140.084 M | -146.402 M |